Literature DB >> 10609969

Effects of abstinence on cigarette smoking among outpatients with schizophrenia.

J W Tidey1, S C O'Neill, S T Higgins.   

Abstract

The authors of this study examined the effects of brief smoking abstinence on smoking among 6 individuals with schizophrenia or schizoaffective disorder. Before 6 of 12 experimental sessions, participants were required to provide breath carbon monoxide (CO) samples indicative of smoking abstinence; before the remaining sessions, participants provided CO samples indicating no abstinence. During sessions, participants obtained smoking opportunities (2 puffs/opportunity) under either fixed ratio-1 or progressive ratio (PR) schedules of reinforcement. Abstinence increased smoking under both schedules and increased breakpoint for smoking under the PR schedule. These data offer further evidence that smoking by individuals with schizophrenia is orderly, operant behavior that is modulated, at least in part, by variables that also affect smoking in people without major mental illness.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10609969     DOI: 10.1037//1064-1297.7.4.347

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  8 in total

1.  Amotivation in schizophrenia: integrated assessment with behavioral, clinical, and imaging measures.

Authors:  Daniel H Wolf; Theodore D Satterthwaite; Jacob J Kantrowitz; Natalie Katchmar; Lillie Vandekar; Mark A Elliott; Kosha Ruparel
Journal:  Schizophr Bull       Date:  2014-03-22       Impact factor: 9.306

2.  Acute effects of D-amphetamine on progressive-ratio performance maintained by cigarette smoking and money.

Authors:  Stacey C Sigmon; Jennifer W Tidey; Gary J Badger; Stephen T Higgins
Journal:  Psychopharmacology (Berl)       Date:  2003-04-09       Impact factor: 4.530

3.  Evaluating the utility of the modified cigarette evaluation questionnaire and cigarette purchase task for predicting acute relative reinforcing efficacy of cigarettes varying in nicotine content.

Authors:  Cecilia L Bergeria; Sarah H Heil; Danielle R Davis; Joanna M Streck; Stacey C Sigmon; Janice Y Bunn; Jennifer W Tidey; Chris A Arger; Derek D Reed; Thomas Gallagher; John R Hughes; Diann E Gaalema; Maxine L Stitzer; Stephen T Higgins
Journal:  Drug Alcohol Depend       Date:  2019-02-13       Impact factor: 4.492

4.  Cigarette demand and delayed reward discounting in nicotine-dependent individuals with schizophrenia and controls: an initial study.

Authors:  James MacKillop; Jennifer W Tidey
Journal:  Psychopharmacology (Berl)       Date:  2011-02-16       Impact factor: 4.530

5.  Methylphenidate does not influence smoking-reinforced responding or attentional performance in adult smokers with and without attention deficit hyperactivity disorder (ADHD).

Authors:  Scott H Kollins; Erin Schoenfelder; Joseph S English; F Joseph McClernon; Rachel E Dew; Scott D Lane
Journal:  Exp Clin Psychopharmacol       Date:  2013-10       Impact factor: 3.157

6.  Effects of smoking abstinence on smoking-reinforced responding, withdrawal, and cognition in adults with and without attention deficit hyperactivity disorder.

Authors:  Scott H Kollins; Joseph S English; Michelle E Roley; Benjamin O'Brien; Justin Blair; Scott D Lane; F Joseph McClernon
Journal:  Psychopharmacology (Berl)       Date:  2012-12-18       Impact factor: 4.530

7.  Temporal horizons of cigarette satiety: determining the window of time over which recent smoking influences motivation to smoke.

Authors:  Benjamin P Kowal; Warren K Bickel; Reid D Landes
Journal:  Behav Pharmacol       Date:  2008-07       Impact factor: 2.293

8.  Response to Reduced Nicotine Content in Vulnerable Populations: Effect of Menthol Status.

Authors:  Danielle R Davis; Mollie E Miller; Joanna M Streck; Cecilia L Bergeria; Stacey C Sigmon; Jennifer W Tidey; Sarah H Heil; Diann E Gaalema; Andrea C Villanti; Maxine L Stitzer; Jeff S Priest; Janice Y Bunn; Joan M Skelly; Valeria Diaz; Christopher A Arger; Stephen T Higgins
Journal:  Tob Regul Sci       Date:  2019-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.